Related Experiment Video
Updated: Feb 24, 2026
12:38
Using Caenorhabditis elegans as a Model System to Study Protein Homeostasis in a Multicellular Organism
Published on: December 18, 2013
6.5K
Modeling stress-induced proteinopathies in Caenorhabditis elegans
Elena Caldero-Escudero1, Silvia Romero-Sanz1
1University of Valladolid, Valladolid, Spain.
Methods in Cell Biology
|February 22, 2026
Summary
Proteinopathies, linked to neurodegenerative diseases, involve toxic protein buildup. This study uses the C. elegans model to detail methods for assessing proteotoxic stress and its cellular impacts.
Area of Science:
- Neurobiology
- Molecular Biology
- Genetics
Background:
- Proteinopathies are characterized by misfolded protein accumulation, causing cellular dysfunction.
- These disorders are hallmarks of age-related neurodegenerative diseases like Alzheimer's and Parkinson's.
- Misfolded proteins impair vital cellular processes, including mitochondrial function and protein degradation.
Purpose of the Study:
- To present methodologies for evaluating proteotoxic stress in C. elegans models.
- To leverage C. elegans' conserved pathways for studying proteinopathy mechanisms.
- To investigate the molecular basis of toxicity in protein misfolding disorders.
Main Methods:
- Utilizing C. elegans as a model organism for proteotoxic stress studies.
- Employing assays for mitochondrial reactive oxygen species (ROS) and membrane potential (Δψm).
- Performing analyses of mitochondrial morphology, oxygen consumption, and protein aggregate quantification.
Main Results:
- C. elegans offers a versatile system due to conserved cellular pathways.
- Established methods allow for comprehensive assessment of proteotoxic stress.
- Quantification of protein aggregates and mitochondrial dysfunction in vivo is feasible.
Conclusions:
- C. elegans is an effective model for dissecting proteinopathy mechanisms.
- The described methodologies provide tools to study cellular responses to proteotoxic stress.
- Understanding these mechanisms can inform therapeutic strategies for neurodegenerative diseases.
